MultiCell Technologies Inc (MCET)

[simon wagstaff]

They certainly are not obvious. There is no ongoing clinical research, there will be no hostile takeover, buy out nor partnership, they have nothing to offer. Just one directly issued patent, liver cells for protein production from a few years ago.There is no liver cancer cure, 10-20 years away even if it were to exist. They do have a patent application for MCT-465 and MCT 485 will was filed a few years ago. Maybe that's the next pump and dump? It will need to come before they go under due to the non-performance clause for the stent. 1.8 billion shares to go.

Hey, it's your money! Good luck!